with the different interfaces. Analysis of each interfaces' maximal effort (CPEF max ) indicated no significant differences (CI 95%, p=0.943). Randomised sequence data was analysed, where it concluded that there was no significant influence of interface sequencing on the Results (CI=95%, p=0.671). Conclusion The study's Results support the hypothesis, suggesting interchangeability of both interfaces. This now offers a platform for further study in the viability of facemask CPEF within the clinical setting, as well as providing a standardised protocol and CPEF reference values.
Introduction Respiratory muscle weakness is a feature of motor neurone disease (MND), develops insidiously and presents with subtle symptoms. It can be difficult to assess in MND patients who, as a result, may be at risk of desaturation at altitude. Hypoxic challenge tests (HCT) can identify patients who would benefit from in-flight oxygen, but evidence as to which patients should be referred is lacking. The aim of this study was to identify factors that may predict the need for in-flight oxygen in this group of patients where maintaining their independence for as long as possible is paramount. Methods 81 consecutive HCT's in 53 male, 28 female patients, and the contemporaneous assessments for respiratory muscle weakness on patients with MND. Data from patients requiring in-flight oxygen according to the HCT was compared to data from patients who did not, in accordance with the BTS Guidance for Air Travel 2011. Results The median patient age of patients who passed the HCT was 62 years; those that failed the HCT were significantly older with a median age of 68 years (p=0.009). There was a significant difference in baseline PaO 2 and PaCO 2 between the groups as shown in Table 1 ; patients who passed the HCT had higher baseline Pa02 and lower PaC02 (10.4 kPa and 5.3 kPa versus 9.3 kPa and 6.2 kPa respectively p=0.0001 and 0.0014). No other parameter, including BMI, smoking history, or physiological measurement including SNIP, or spirometry, could predict the outcome of the HCT. Conclusions Although MND patients that are likely to fail a HCT have a higher baseline C02, a threshold C02 value that could identify patients needing in-flight oxygen was not determined. We recommend that the safest approach is to refer all patients with MND that intend to fly for HCT assessment until more evidence-based data is available, which is the current practice at this regional centre. Introduction Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare condition characterised by a generalised proliferation of pulmonary neuroendocrine cells within the respiratory epithelium. Current literature is limited, in particular little is known of its affects on pulmonary function both at the time of diagnosis and prospectively, though it is recognised to cause small airway obstruction.
Objective The aim of this study was to characterise pulmonary function, both at baseline and to also define the change in pulmonary function over time in patients with DIPNECH. Methods Retrospective analysis of pulmonary function data for patients with a histological diagnosis of DIPNECH was performed. At baseline, pulmonary function was characterised as either obstructive, small airways obstruction, restrictive, mixed (obstructive and restrictive) or normal. Baseline gas transfer (DLCO) and lung volume data was also described. FEV1 was used as the main measure of pulmonary function, and simple linear regressions were created for patients with longitudinal data. This then allowed basic statistical analysis of the change in FEV1 compared to the predicted change.
Results 17 patients (82% female), with a mean age of 59, were included. All had pulmonary function data at baseline and 9 (53%) had prospective data. Baseline pulmonary function was predominantly obstructive in nature with 6 (35%) having classical obstruction, and 7 (41%) small airways obstruction alone with a normal FEV1/FVC ratio, the remaining 4 having either normal (n=3, 23%) or mixed (n=1, 6%) physiology. The mean FEV1 at baseline was 81.6%, and a statistically significant difference was present between mean measured and predicted FEV1 values for the cohort (p=0.02). Mean DLCO (n=13) was mildly decreased at 84.6% predicted however corrected to normal with volume. Lung volume data (n=8) where available was normal, except in two patients (12%) who had significantly increased residual volume. Patients with longitudinal data (n=9, 53%) predominantly showed a stable pattern of obstruction with minimal decline. Two patients (12%) did have a significantly increased decline compared to predicted values. Conclusion Patients with DIPNECH typically have a stable degree of fixed obstruction, however exceptions to this will be seen in patients with a more progressive disease. Introduction Hypoxic challenge test consisting of breathing 15% FiO2 for 20 min with blood gas measurements is recommended by BTS guidelines for the assessment of the requirement for in-flight oxygen. FEV1 and SpO2 have been demonstrated to be poor predictors of desaturation with no established reliable upper limit of PaO2, above which patients will not desaturate. We investigated whether there were lowerlimit thresholds, beyond which oxygen is always required and hence HCT can be avoided.
P142 HYPOXIC CHALLENGE TEST (HCT) FOR IN-FLIGHT OXYGEN ASSESSMENTS CAN BE AVOIDED IN PATIENTS WITH LUNG DISEASE AND LOW RESTING PAO2
Methods Retrospective analysis of all hypoxic challenge tests conducted at our centre between 2010 and 2017 was undertaken. Baseline demographics, diagnosis and contemporaneous lung function data was recorded. HCT was performed as per BTS guidance and included baseline resting blood gas followed by a repeat after 20 min inspiring 15% FiO2. If PaO2 was <6.65 kPa or SpO2 <85%, 2 L oxygen via nasal cannulae was applied and a repeat blood gas performed to confirm PaO2 6.65 kPa. Introduction Since its initial description in 1904, the oxygenhaemoglobin dissociation curve (ODC) has been well described under physiological conditions. 1,2 However, the impact of pathology has been less well characterised, with most data arising from small clinical studies of anaesthetized adults/ patients (<100 subjects), or experimentally-induced hypoxaemia/hypercapnia. Routinely collected clinical data, including arterial blood gas analyses, are now available from many thousands of critically ill patients. We sought to investigate the impact of pCO 2 on the ODC of critically ill adults, and hypothesised that pCO 2 would not significantly alter the relationship between pO 2 and haemoglobin saturation. Methods Data was extracted from the National Institute for Health Research Critical Care Health Informatics Collaborative (NIHR ccHIC). Statistical analysis was undertaken on 3 99 000 blood gases from 13 942 patients, using R version 3.4.0. After data cleaning, the predicted oxygen saturation for each arterial blood gas sample was calculated using both the Severinghaus 1 and Dash, Kroman and Bassingthwaighte 2 equations. Non-linear regression modelling was undertaken to construct ODCs based on both the predicted and observed data,
